Complex Regional Pain Syndrome (CRPS) is a long-term pain that affects a limb, such as the arm, leg, hand, or foot, after a traumatic injury. CRPS is due to internal nerve damage in the limb. CRPS is defined by extreme pain in the area and changes in skin color, temperature, and inflammation/swelling of the area. Symptoms vary depending on the severity and duration of the pain.
There are two types of CRPS. Type I CRPS (CRPS-I) occurs when affected individuals do not have confirmed nerve injury, and is also known as reflex sympathetic dystrophy syndrome. Type II (CRPS-II) is when there is confirmed nerve injury, also known as causalgia. Treatment for both types are similar.
There are three stages of the disease.
Stage I is the acute phase and can last up to 3 months. There is increased sensitivity to touch and pain. The pain is constant and long. The joints are swollen and stiff. There is increased warmness and redness. Excessive sweating and fast nail and hair growth can be present.
Stage II is the dystrophic phase (showing degeneration of tissues) and can last from 3 to 12 months. Swelling and inflammation persist. Wrinkles disappear because of the tightness of the skin and swelling. Nails and hair become brittle and weak. Pain increases and spread. Stiffness and sensitivity increase.
Stage III is the atrophic phase (the loss of tissues) and can last for 12 months or more. The skin is tight, dry, shinny, and pale. The affected area is stiff and motion cannot be regained. Pain is decreases in the affected area and spreads to other areas.
Complex Regional Pain Syndrome (CRPS) is a long-term pain that affects a limb, such as the arm, leg, hand, or foot, after a traumatic injury. CRPS is due to internal nerve damage in the limb. CRPS is defined by extreme pain in the area and changes in skin color, temperature, and inflammation/swelling of the area. Symptoms vary depending on the severity and duration of the pain.
There are two types of CRPS. Type I CRPS (CRPS-I) occurs when affected individuals do not have confirmed nerve injury, and is also known as reflex sympathetic dystrophy syndrome. Type II (CRPS-II) is when there is confirmed nerve injury, also known as causalgia. Treatment for both types are similar.
There are three stages of the disease.
Stage I is the acute phase and can last up to 3 months. There is increased sensitivity to touch and pain. The pain is constant and long. The joints are swollen and stiff. There is increased warmness and redness. Excessive sweating and fast nail and hair growth can be present.
Stage II is the dystrophic phase (showing degeneration of tissues) and can last from 3 to 12 months. Swelling and inflammation persist. Wrinkles disappear because of the tightness of the skin and swelling. Nails and hair become brittle and weak. Pain increases and spread. Stiffness and sensitivity increase.
Stage III is the atrophic phase (the loss of tissues) and can last for 12 months or more. The skin is tight, dry, shinny, and pale. The affected area is stiff and motion cannot be regained. Pain is decreases in the affected area and spreads to other areas.
CRPS is more prevalent in women, but can occur in men. It can occur at any age, but peaks at age 40. It is rarely seen in the elderly and children.
Most cases of CRPS is caused by trauma or injury. However, there may be rare cases of CRPS without trauma or cases of severe trauma without CRPS. The most common injuries are fractures, sprains, burns, bruises, cuts, limb immobilization (limb cast or splint), surgery or needles sticks. CRPS is an abnormally painful response to an injury.
In healthy individuals, myelin surrounds the peripheral sensory nerve fibers, called axons, that deliver the sensation of pain and sends messages to the blood vessels. In affected individuals the axon or nerves are unmyelinated or thinly myelinated and potentiates the feeling of pain. In CRPS, the symptoms are triggered by damage to nerve fibers in close proximity with blood vessels, producing inflammation and pain. The blood vessels can over constrict and cause white/blue skin or dilate and cause red/swollen skin. Damage to these nerves can trigger further damage in the spinal cord and/or brain.
There is limited data on CRPS being cause by genetics.
The primary symptom is constant severe pain. The pain is often described as a burning, squeezing, or “pins and needles” sensation. The pain typically radiates throughout the limb even if the initial injury was only on a toe or finger. The pain can also travel to the opposite limb in rare cases. Increased sensitivity to pain is common in the affected area called allodynia.
Other symptoms of CRPS include the following:
Name | Description |
---|---|
Burning pain | Burning pain at the site of the injury |
Increased skin sensitivity | Increased skin sensitivity |
Swelling and stiffness | Swelling and stiffness in affected joints |
Muscle spasm | Muscle spasm |
Restricted mobility | Restricted mobility |
Rapid or weak hair and nail growth | Rapid or weak hair and nail growth |
Vasospasm | Constriction of the blood vessels |
Insomnia | Insomnia |
Mottled/Glassy Skin | mottled/glassy skin |
Diagnosis is based a clinical evaluation of the patient’s symptoms and medical history. Detailed examination by a doctor or specialist is important to rule out other conditions with similar symptoms. Most affected individuals can have symptom improvement over time. Diagnosis can be difficult in the latter end of the condition.
There is no specific test to confirm or diagnose CRPS. Magnetic resonance imaging (MRI) or triple phase bone scans can help confirm a diagnosis.
Rehabilitation or physical therapy is the primary treatment. Exercise can help keep the affected limb mobile, improved flexibility and strength, increase blood flow, and decrease symptoms. Rehabilitation helps improve motion and slow-down secondary brain changes due to the chronic pain. Occupational therapy can help individuals learn new ways to do daily tasks.
There is currently no FDA-approved (U.S. Food and Drug Administration) medication indicated specifically for CRPS. There are drugs that can help manage or improve CPRS symptoms, such as:
There are other treatments that have been tried, but not proven effective, such as: sympathetic nerve block, surgical sympathectomy, spinal cord stimulation, and neural stimulation.
Other treatments in the trial phase are intravenous immunoglobulin (IVIG) and graded motor imagery. Graded motor imagery is the process of doing mental exercises in front of the mirror and visualize moving the painful body parts without moving them.
Alternative therapies are acupuncture, behavior modification, chiropractic treatment, and relaxation techniques.
The outcome of CRPS is variable. Affected individuals with mild to moderate symptom and pain can recover. Affected individuals with severe and debilitating symptom and pain may not recover and may have long-term disability. Younger individuals typically have better outcomes than older individuals.
The reason behind advanced regional pain syndrome is not clearly understood. Treatment for advanced regional pain syndrome is best once started early. In such cases, improvement and even remission are attainable.
Title | Description | Date | Link |
---|---|---|---|
Reflex Sympathetic Dystrophy Syndrome Association (RSDSA) |
The Reflex Sympathetic Dystrophy Syndrome Association (RSDSA) was founded in 1984 to promote public and professional awareness of Complex Regional Pain Syndrome (CRPS), formerly known as Reflex Sympathetic Dystrophy (RSD). |
03/20/2017 |
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Having read what I wrote here while confined to my hospital room on day three of my current stint for very low hematocrit values (<2.5) (July 2021)
I realize how atrocious what I had...
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Created by Melisquent | Last updated 18 Nov 2015, 05:02 AM
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITYOur rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.